Muscarinic receptors, leukotriene B4 production and neutrophilic inflammation in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 20s Year: 2004
The effects of a cysteinyl leukotriene receptor antagonist, pranlukast, on dendritic cell chemoattractants in the airways of subjects with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 132s Year: 2004
Upregulation of cysteinyl leukotriene receptors CysLT1 and CysLT2 by TGF-β1 and LTE4 on human bronchial epithelial cells Source: Annual Congress 2006 - Airway epithelial cells in inflammation Year: 2006
The CysLT1 receptor antagonist montelukast inhibits mast cell activation induced by inhaled leukotriene E4 in subjects with asthma Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016
Expression of surface receptors on alveolar macrophages and monocytes from patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 453s Year: 2004
Increased expression of the cysteinil leukotriene 1 receptor (CysLT1-R) in the bronchial epithelium of smokers Source: Eur Respir J 2001; 18: Suppl. 33, 74s Year: 2001
Expression of muscarinic receptors by sputum cells of control and COPD patients and release of LTB4 after acethylcholine stimulation Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002
Do leukotriene antagonists reduce eosinophil numbers in induced sputum from asthmatic patients as a consequence of increased apoptosis induction? Source: Eur Respir J 2002; 20: Suppl. 38, 584s Year: 2002
Expression of muscarinic M5 receptors on tissue lymphocytes and alveolar macrophages in mild and severe COPD Source: Annual Congress 2008 - Basic science in asthma and COPD II Year: 2008
Expression of the cysteinyl leukotriene receptors cysLT1 and cysLT2 in the airway structural cells Source: Eur Respir J 2005; 26: Suppl. 49, 346s Year: 2005
Expression of toll-like receptor 3 in alveolar macrophages from patients with COPD Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics Year: 2010
Chronic obstructive pulmonary disease is characterized with suppressed lipoxin A4 and increased lipoxin receptor expression in lungs Source: Annual Congress 2012 - The smoking gun in COPD biology Year: 2012
Effects of a leukotriene B4 receptor antagonist on bleomycin-induced pulmonary fibrosis Source: Eur Respir J 2009; 34: 1444-1451 Year: 2009
Effect of muscarinic receptors inhibition on cytokine release and inflammatory cells infiltration in the airway of cat as an animal model for COPD Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012
Leukotriene B4 levels in sputum from asthma patients Source: ERJ Open Res, 2 (4) 00088-2015; 10.1183/23120541.00088-2015 Year: 2016
LPS-induced TLR4 expression and cytokine release is impaired in monocytes and T-lymphocytes of COPD patients Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD Year: 2008
Human neutrophil peptides stimulate the production of TNF alpha by alveolar macrophages from patients with sarcoidosis Source: Annual Congress 2007 - Inflammatory cell biology Year: 2007
Intranasal administration of leukotriene B4 selectively increases human nasal neutrophil activity Source: Annual Congress 2008 - Phenotyping of asthma and COPD Year: 2008
Eosinophil activation and cysteinyl leukotriene production in infants with RSV positive bronchiolitis Source: Eur Respir J 2001; 18: Suppl. 33, 180s Year: 2001
Increased in vitro production of IP-10/CXCL10 and MIG/CXCL9 by alveolar macrophages in sarcoidosis and EAA but not in IPF Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008